Top Markets
Coin of the day
Theralase Technologies Inc. Theralase Technologies Inc.

Theralase Technologies Inc.

TLT
Classificação em ações #26098
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages... Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Preço da ação
$0.14678738
Valor de mercado
$43.40M
Variação (1 dia)
14.29%
Variação (1 ano)
-7.44%
País
CA
Negociar Theralase Technologies Inc. (TLT)

Categoria

Histórico de desdobramentos de ações de Theralase Technologies Inc. (TLT)
As ações Theralase Technologies Inc. (símbolo: TLT) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 20, 2026.
Uma ação TLT comprada antes de Aug 20, 2026 equivaleria hoje a 0 ações TLT.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE